Impact Biomedical (IBO) Accumulated Expenses (2022 - 2026)
Impact Biomedical (IBO) posted Accumulated Expenses of $210000.0 for Q1 2026, up 8.25% on a QoQ basis from $194000.0 in Q4 2025, and down 3.23% year-over-year from $217000.0 in Q1 2025.
Impact Biomedical (IBO) Accumulated Expenses (2022 - 2026) Analysis & Trends
Impact Biomedical's Accumulated Expenses history runs 5 years deep, the most recent figure standing at $210000.0 for Q1 2026.
- Quarterly Accumulated Expenses fell 3.23% year-over-year to $210000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $210000.0 (down 3.23% YoY) and the FY2025 annual result came in at $194000.0, changed 0.0% from the prior year.
- Accumulated Expenses was $210000.0 for Q1 2026 at Impact Biomedical, up from $194000.0 in the prior quarter.
- Across five years, Accumulated Expenses topped out at $336000.0 in Q3 2025 and bottomed at $6000.0 in Q3 2023.
- A 5-year average of $160500.0 and a median of $194000.0 in 2024 frame the typical range for Accumulated Expenses.
- Peak annual rise in Accumulated Expenses reached 1600.0% in 2024, while the deepest fall reached 15.65% in 2024.
- Impact Biomedical's Accumulated Expenses stood at $63000.0 in 2022, then jumped by 265.08% to $230000.0 in 2023, then retreated by 15.65% to $194000.0 in 2024, then changed by 0.0% to $194000.0 in 2025, then grew by 8.25% to $210000.0 in 2026.
- Business Quant data shows IBO's Accumulated Expenses at $210000.0 in Q1 2026, $194000.0 in Q4 2025, and $336000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 210,000.00 |
| Dec 31, 2025 | 194,000.00 |
| Sep 30, 2025 | 336,000.00 |
| Jun 30, 2025 | 266,000.00 |
| Mar 31, 2025 | 217,000.00 |
| Dec 31, 2024 | 194,000.00 |
| Sep 30, 2024 | 102,000.00 |
| Jun 30, 2024 | 61,000.00 |
| Mar 31, 2024 | 47,000.00 |
| Dec 31, 2023 | 230,000.00 |
| Sep 30, 2023 | 6,000.00 |
| Dec 31, 2022 | 63,000.00 |